Although much remains to be learned regarding the biological basis of the relationship between the FMO3 gene and hypertension risk, it is already clear that further studies focusing on the investigation of gene-environment interactions may improve our understanding of the disease pathogenesis and define novel therapeutic and preventive options as a means of personalized medicine in cardiologic practice. The gene discussed is FMO3; the disease is Hypertension.